References
- Covens A, Rosen B, Murphy J, et al (2002). How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol, 84, 145-9. https://doi.org/10.1006/gyno.2001.6493
- Delgado G, Bundy B, Zaino R, et al (1990). Prospective surgicalpathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38, 352-7. https://doi.org/10.1016/0090-8258(90)90072-S
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-7. https://doi.org/10.1002/ijc.25516
- Frumovitz M, Sun CC, Schmeler KM, et al (2009). Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol, 114, 93-9. https://doi.org/10.1097/AOG.0b013e3181ab474d
- Garg G, Shah JP, Toy EP, et al (2011). Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival? Int J Gynecol Cancer, 21, 711-6. https://doi.org/10.1097/IGC.0b013e3182138648
- Ho CM, Chien TY, Huang SH, et al (2004). Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol, 93, 458-64. https://doi.org/10.1016/j.ygyno.2004.01.026
- Hopkins MP, Morley GW (1991). Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer, 68, 272-7. https://doi.org/10.1002/1097-0142(19910715)68:2<272::AID-CNCR2820680210>3.0.CO;2-X
- Horn LC, Fischer U, Raptis G, et al (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107, 310-5. https://doi.org/10.1016/j.ygyno.2007.06.026
- Hosaka M, Watari H, Mitamura T, et al (2011). Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol, 16, 33-8. https://doi.org/10.1007/s10147-010-0123-0
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Lai CH, Hsueh S, Hong JH, et al (1999). Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer, 9, 28-36. https://doi.org/10.1046/j.1525-1438.1999.09895.x
- Lai JC, Chou YJ, Huang N, et al (2013). Survival analysis of Stage IIA1 and IIA2 cervical cancer patients. Taiwan J Obstet Gynecol, 52, 33-8. https://doi.org/10.1016/j.tjog.2013.01.006
- Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40. https://doi.org/10.1016/S0140-6736(97)02250-2
- Landoni F, Zanagnolo V, Lovato-Diaz L, et al (2007). Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer, 17, 623-8. https://doi.org/10.1111/j.1525-1438.2006.00854.x
- Mabuchi S, Okazawa M, Matsuo K, et al (2012). Impact of histological subtype on survival of patients with surgicallytreated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol, 127, 114-20. https://doi.org/10.1016/j.ygyno.2012.06.021
- Macdonald OK, Chen J, Dodson M, et al (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol, 32, 411-6. https://doi.org/10.1097/COC.0b013e31819142dc
- Ngamcherttakul V, Ruengkhachorn I (2012). Ovarian metastasis and other ovarian neoplasms in women with cervical cancer stage IA-IIA. Asian Pac J Cancer Prev, 13, 4525-9. https://doi.org/10.7314/APJCP.2012.13.9.4525
- Pecorelli S, Zigliani L, Odicino F (2009). Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet, 105, 107-8. https://doi.org/10.1016/j.ijgo.2009.02.009
- Perez CA, Grigsby PW, Chao KS, et al (1998). Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys, 41, 307-7. https://doi.org/10.1016/S0360-3016(98)00067-4
- Peters WA, III, Liu PY, Barrett RJ, et al (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18, 1606-13.
- Quinn MA, Benedet JL, Odicino F, et al (2006). Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, 43-103. https://doi.org/10.1016/S0020-7292(06)60030-1
- Sakuragi N (2007). Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol, 12, 165-75. https://doi.org/10.1007/s10147-007-0661-2
- Shimada M, Kigawa J, Nishimura R, et al (2006). Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol, 101, 234-7. https://doi.org/10.1016/j.ygyno.2005.10.004
- Soisson AP, Soper JT, Clarke-Pearson DL, et al (1990). Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol, 37, 390-5. https://doi.org/10.1016/0090-8258(90)90374-T
- Steed H, Capstick V, Schepansky A, et al (2006). Early cervical cancer and parametrial involvement: is it significant? Gynecol Oncol, 103, 53-7. https://doi.org/10.1016/j.ygyno.2006.01.027
- Sutton GP, Bundy BN, Delgado G, et al (1992). Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol, 166, 50-3. https://doi.org/10.1016/0002-9378(92)91828-X
- Takeda N, Sakuragi N, Takeda M, et al (2002). Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand, 81, 1144-51. https://doi.org/10.1034/j.1600-0412.2002.811208.x
- Trattner M, Graf AH, Lax S, et al (2001). Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol, 82, 11-6. https://doi.org/10.1006/gyno.2001.6252
- Verleye L, Vergote I, Reed N, et al (2009). Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer--Gynecological Cancer Group (EORTC-GCG). Ann Oncol, 20, 1631-8. https://doi.org/10.1093/annonc/mdp196
Cited by
- Prognostic Evaluation of Tumor-Stroma Ratio in Patients with Early Stage Cervical Adenocarcinoma Treated by Surgery vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4363
- A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer vol.26, pp.8, 2016, https://doi.org/10.1097/IGC.0000000000000786
- Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer? vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-2927-5
- Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma vol.46, pp.10, 2018, https://doi.org/10.1177/0300060518785827